A detailed history of Allstate Investment Management CO transactions in Moderna, Inc. stock. As of the latest transaction made, Allstate Investment Management CO holds 14,190 shares of MRNA stock, worth $558,944. This represents 0.08% of its overall portfolio holdings.

Number of Shares
14,190
Holding current value
$558,944
% of portfolio
0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $1.68 Million - $2.98 Million
14,190 New
14,190 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Allstate Investment Management CO Portfolio

Follow Allstate Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Investment Management CO with notifications on news.